Caremark

Massachusetts Leads Investigation Resulting in $36.7 Million Settlement with the U.S. Government, 23 States and the District of Columbia

March 18, 2008 -- BOSTON – Today, the Office of Massachusetts Attorney General Martha Coakley, along with federal authorities, 23 other states, and the District of Columbia, entered into a settlement agreement with CVS/Caremark Corporation to settle allegations of billing improprieties.    » read more »

CVS/Caremark to Pay More Than $800,000 to Maryland’s Medicaid Program

BALTIMORE, MD (March 18, 2008) – Maryland Attorney General Douglas F. Gansler today announced a $36.7 million federal and multistate settlement with CVS/Caremark Corporation to resolve allegations of improper billing. The payment, of which Maryland’s Medicaid Program will receive $830,490, resolves claims that CVS violated state and federal statutes and regulations by switching dosage forms of ranitidine, an antacid medication commonly prescribed for Medicaid patients.    » read more »

March 18, 2008 -- Kentucky Attorney General Jack Conway announced today that Kentucky will receive a $1.36 million settlement from CVS Caremark Corporation for defrauding the state Medicaid program.    » read more »

March 18, 2008 -- (INDIANAPOLIS, IN) - CVS/Caremark Corporation has agreed to pay $1,406,120 to the Indiana Medicaid Program to settle allegations of improper billing announced Indiana Attorney General Steve Carter today. The payment is part of a $36.7 million settlement with the United States, 23 states and the District of Columbia and resolves claims that CVS pharmacies systemically switched the dosage form of ranitidine from tablet-form to the capsule-form of the drug. The CVS will repay Indiana $513,962 for the state’s share of the Medicaid loss.    » read more »

Nationwide settlement addresses dosage switching of generic antacid

March 18, 2008 -- TALLAHASSEE, FL - Florida Attorney General Bill McCollum announced today that the Florida Medicaid program will receive more than $186,000 from a $36.7 million multistate settlement with CVS and Caremark Corporation. The settlement with the United States, 23 states and the District of Columbia resolves allegations that CVS violated various state and federal statutes and regulations by switching dosage forms of an antacid medication commonly prescribed for Medicaid patients.    » read more »